Inhibition of colorectal cancer cell proliferation by a specific monoclonal PLSCR1 antibody in vitro
碩士 === 長庚大學 === 生化與生醫工程研究所 === 100 === In recent years, colorectal cancer has ranked in the most common cancer and the third most frequent cause deaths in Taiwan. Although there are some molecular target drugs available for cancers, there appears to be urgent needs for the colorectal cancer due to i...
Main Authors: | Wei Shan Wei, 魏薇珊 |
---|---|
Other Authors: | E. C. Chan |
Format: | Others |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/47230506615887450528 |
Similar Items
-
Develop PLSCR1 as a serological biomarker in plasma for colorectal cancer
by: Yun Jan Lin, et al.
Published: (2011) -
Mechanism of phospholipid scramblase 1 (PLSCR1) involved in colorectal cancer tumorigenesis
by: Chun Yu Chen, et al.
Published: (2014) -
Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
by: Kyusang Hwang, et al.
Published: (2021-01-01) -
Inhibition of CTHRC-1 by its specific monoclonal antibody attenuates cervical cancer cell metastasis
by: Xiao-xiao Cui, et al.
Published: (2019-02-01) -
Characterization and potential applications of the CCN1-specific monoclonal antibodies in breast cancers
by: Tsai-Wei Tsai, et al.
Published: (2012)